General
| Peptide: | Lys-a1 |
| Microorganism: | Streptococcus sanguinis ATCC 10556 |
| Administration: | |
| Stage: | Formation (3-24h) |
| Notes: |
Experimental procedure
| Method | AMP Effect(Biofilm reduction) | Concentration | Notes |
|---|---|---|---|
| Crystal violet assay | 51 - 90% | 3.777 uM | |
| Crystal violet assay | > 90% | 7.553 uM | |
| Total countable CFUs | >= 3 log | 1.888 uM |
Reference
- Bruno Rocha da Silva, Victor Aragão Abreu de Freitas, Victor Alves Carneiro, Francisco Vassiliepe Sousa Arruda, Esteban Nicolás Lorenzón, Andréa Silvia Walter de Aguiar, Eduardo Maffud Cilli, Benildo Sousa Cavada, Edson Holanda Teixeira Antimicrobial activity of the synthetic peptide Lys-a1 against oral streptococci
M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.
Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com